Intranasal Tranexamic Acid for Anterior Nosebleeds
common.study.values.description
“Intranasal TXA for Anterior Epistaxis in the Emergency Department”
The objective of this study is to evaluate the efficacy of and patient satisfaction with the use of intranasal tranexamic acid (TXA) for anterior nosebleeds in the emergency department (ED).
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Tranexamic Acid
Enrolled patients will be placed in one of two groups: either the group receiving a cotton pledget soaked in (0.9%) saline or (100mg/1mL) TXA. Patients will initially be asked to gently blow their nose to remove any clots. Group 1 will receive the saline soaked pledget. After fifteen minutes the pledget will be removed. If patient continues to bleed within a reevaluation period of fifteen minutes, this will be deemed a 'failure' and the examiner will pack the nose with the method of his or her c ...read more on ClinicalTrials.org
Placebo
This group will receive pledget soaked in saline. Protocol will continue as with TXA group.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Intranasal TXA for Anterior Epistaxis in the Emergency Department
common.study.values.clinical-trial-id
NCT04054687
participant.views.study.view.id
dwpD1e
